Loading…
Identification of Amino Acid Residues Important for Sarpogrelate Binding to the Human 5-Hydroxytryptamine2A Serotonin Receptor
The purpose of the present study was to examine 5-hydroxytryptamine (5-HT)2A-receptor sarpogrelate interactions by site-directed mutagenesis. Based on molecular modeling studies, aspartic acid (Asp)155[3.32] and tryptophan (Trp)151[3.28] in transmembrane helix (TMH) III and Trp336[6.48] in TMH VI of...
Saved in:
Published in: | Journal of Pharmacological Sciences 2006, Vol.102(1), pp.55-63 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c6561-80e5653bda862b7fc95884e7c172d2e905087dc6a3d58b0e98a868e90a5c90753 |
---|---|
cites | cdi_FETCH-LOGICAL-c6561-80e5653bda862b7fc95884e7c172d2e905087dc6a3d58b0e98a868e90a5c90753 |
container_end_page | 63 |
container_issue | 1 |
container_start_page | 55 |
container_title | Journal of Pharmacological Sciences |
container_volume | 102 |
creator | Muntasir, Habib Abul Rashid, Mamunur Komiyama, Tadazumi Kawakami, Jun Nagatomo, Takafumi |
description | The purpose of the present study was to examine 5-hydroxytryptamine (5-HT)2A-receptor sarpogrelate interactions by site-directed mutagenesis. Based on molecular modeling studies, aspartic acid (Asp)155[3.32] and tryptophan (Trp)151[3.28] in transmembrane helix (TMH) III and Trp336[6.48] in TMH VI of the 5-HT2A receptor were found to interact with sarpogrelate. All of these residues were mutated to alanine (Ala). The Asp3.32Ala mutant did not exhibit any affinity for [3H]ketanserin, whereas the Trp3.28Ala mutant showed a markedly decrease in the binding affinity for [3H]ketanserin (Kd >10,000 nM). Therefore, it was not possible to find any sarpogrelate affinity to the mutants using [3H]ketanserin. The mutation also abolished agonist-stimulated formation of [3H]inositol phosphates (IP) in both cases. On the other hand, the Trp6.48Ala mutant showed reduced binding affinity for [3H]ketanserin (Kd 2.0 nM vs 0.8 nM for the wild-type receptor) and had reduced affinity for sarpogrelate (pKi value of 5.71 vs 9.06 for the wild-type receptor). The Trp6.48Ala mutant also showed the greatest decrease in sensitivity to sarpogrelate (pKb value 8.81 for wild-type and 5.11 for mutant) in inhibiting agonist-stimulated IP formation. These results provide direct evidence that Asp3.32, Trp3.28, and less importantly, Trp6.48 are responsible for the interaction between the 5-HT2A receptor and sarpogrelate. In addition, these results support the findings obtained from molecular modeling studies. |
doi_str_mv | 10.1254/jphs.FP0060171 |
format | article |
fullrecord | <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ce111e66bd294ef69ae4f21f741d38ca</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1347861319344160</els_id><doaj_id>oai_doaj_org_article_ce111e66bd294ef69ae4f21f741d38ca</doaj_id><sourcerecordid>16974069</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6561-80e5653bda862b7fc95884e7c172d2e905087dc6a3d58b0e98a868e90a5c90753</originalsourceid><addsrcrecordid>eNp1kU2P0zAQhiMEYj_gyhH5D7TYSew4x7KitNJKIBbOlmNPWlepHdku2l747UybbjlxmbHGM898vEXxgdE5K3n9aTdu03z5nVJBWcNeFbesqpuZFLV8fX2z6qa4S2lHaSkpE2-LGybapqaivS3-rC347HpndHbBk9CTxd75QBbGWfIDkrMHSGS9H0PM2mfSh0iedBzDJsKgM5DPzlvnNyQHkrdAVoe99oTPVkcbw_Mxx-OYNRKhXJAniCEH7zyCDYw5xHfFm14PCd5f_H3xa_nl58Nq9vjt6_ph8Tgzggs2kxS44FVntRRl1_Sm5VLW0BjWlLaElnIqG2uEriyXHYVWYqLEuOampQ2v7ov1xLVB79QY3V7HowraqXMgxI3SMTszgDLAGAMhOlu2NfSi1VD3JeubmtlKGo2s-cQyMaQUob_yGFUnUdRJFHUVBQs-TgXjoduD_Zd-UQETllMC_qIQQ_ADHkztwiF6vIoyvUjGgVclIhVltKTs5BSlnKMRVSuxr0DQYgLtUtYbuHZ62e08GJYrdrFYft17q6MCjww5MQD1-O0gqnNvg6NFMBkP5v636F9myMqa</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Identification of Amino Acid Residues Important for Sarpogrelate Binding to the Human 5-Hydroxytryptamine2A Serotonin Receptor</title><source>ScienceDirect Journals</source><creator>Muntasir, Habib Abul ; Rashid, Mamunur ; Komiyama, Tadazumi ; Kawakami, Jun ; Nagatomo, Takafumi</creator><creatorcontrib>Muntasir, Habib Abul ; Rashid, Mamunur ; Komiyama, Tadazumi ; Kawakami, Jun ; Nagatomo, Takafumi ; Department of Cardiovascular Medicine ; Department of Pharmacology ; Tohoku University ; Niigata University of Pharmacy and Applied Life Sciences ; Graduate School of Medicine ; Faculty of Pharmaceutical Sciences ; Department of Biochemistry</creatorcontrib><description>The purpose of the present study was to examine 5-hydroxytryptamine (5-HT)2A-receptor sarpogrelate interactions by site-directed mutagenesis. Based on molecular modeling studies, aspartic acid (Asp)155[3.32] and tryptophan (Trp)151[3.28] in transmembrane helix (TMH) III and Trp336[6.48] in TMH VI of the 5-HT2A receptor were found to interact with sarpogrelate. All of these residues were mutated to alanine (Ala). The Asp3.32Ala mutant did not exhibit any affinity for [3H]ketanserin, whereas the Trp3.28Ala mutant showed a markedly decrease in the binding affinity for [3H]ketanserin (Kd >10,000 nM). Therefore, it was not possible to find any sarpogrelate affinity to the mutants using [3H]ketanserin. The mutation also abolished agonist-stimulated formation of [3H]inositol phosphates (IP) in both cases. On the other hand, the Trp6.48Ala mutant showed reduced binding affinity for [3H]ketanserin (Kd 2.0 nM vs 0.8 nM for the wild-type receptor) and had reduced affinity for sarpogrelate (pKi value of 5.71 vs 9.06 for the wild-type receptor). The Trp6.48Ala mutant also showed the greatest decrease in sensitivity to sarpogrelate (pKb value 8.81 for wild-type and 5.11 for mutant) in inhibiting agonist-stimulated IP formation. These results provide direct evidence that Asp3.32, Trp3.28, and less importantly, Trp6.48 are responsible for the interaction between the 5-HT2A receptor and sarpogrelate. In addition, these results support the findings obtained from molecular modeling studies.</description><identifier>ISSN: 1347-8613</identifier><identifier>EISSN: 1347-8648</identifier><identifier>DOI: 10.1254/jphs.FP0060171</identifier><identifier>PMID: 16974069</identifier><language>eng</language><publisher>Japan: Elsevier B.V</publisher><subject>5-HT2A receptor ; 5-hydroxytryptamine (5-HT) ; Amino Acids - metabolism ; Animals ; Binding, Competitive - drug effects ; Blotting, Western ; Cell Line ; Cells, Cultured ; Cercopithecus aethiops ; COS Cells ; DNA - genetics ; Humans ; Inositol Phosphates - metabolism ; Ketanserin - metabolism ; Ligands ; Models, Molecular ; molecular modeling ; Mutagenesis, Site-Directed ; Receptor, Serotonin, 5-HT2A - genetics ; Receptor, Serotonin, 5-HT2A - metabolism ; sarpogrelate ; Serotonin Antagonists - metabolism ; Serotonin Receptor Agonists - pharmacology ; site-directed mutagenesis ; Succinates - metabolism ; Transfection</subject><ispartof>Journal of Pharmacological Sciences, 2006, Vol.102(1), pp.55-63</ispartof><rights>2006 Elsevier B.V.</rights><rights>The Japanese Pharmacological Society 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6561-80e5653bda862b7fc95884e7c172d2e905087dc6a3d58b0e98a868e90a5c90753</citedby><cites>FETCH-LOGICAL-c6561-80e5653bda862b7fc95884e7c172d2e905087dc6a3d58b0e98a868e90a5c90753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1347861319344160$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3536,4010,27904,27905,27906,45761</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16974069$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muntasir, Habib Abul</creatorcontrib><creatorcontrib>Rashid, Mamunur</creatorcontrib><creatorcontrib>Komiyama, Tadazumi</creatorcontrib><creatorcontrib>Kawakami, Jun</creatorcontrib><creatorcontrib>Nagatomo, Takafumi</creatorcontrib><creatorcontrib>Department of Cardiovascular Medicine</creatorcontrib><creatorcontrib>Department of Pharmacology</creatorcontrib><creatorcontrib>Tohoku University</creatorcontrib><creatorcontrib>Niigata University of Pharmacy and Applied Life Sciences</creatorcontrib><creatorcontrib>Graduate School of Medicine</creatorcontrib><creatorcontrib>Faculty of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Department of Biochemistry</creatorcontrib><title>Identification of Amino Acid Residues Important for Sarpogrelate Binding to the Human 5-Hydroxytryptamine2A Serotonin Receptor</title><title>Journal of Pharmacological Sciences</title><addtitle>J Pharmacol Sci</addtitle><description>The purpose of the present study was to examine 5-hydroxytryptamine (5-HT)2A-receptor sarpogrelate interactions by site-directed mutagenesis. Based on molecular modeling studies, aspartic acid (Asp)155[3.32] and tryptophan (Trp)151[3.28] in transmembrane helix (TMH) III and Trp336[6.48] in TMH VI of the 5-HT2A receptor were found to interact with sarpogrelate. All of these residues were mutated to alanine (Ala). The Asp3.32Ala mutant did not exhibit any affinity for [3H]ketanserin, whereas the Trp3.28Ala mutant showed a markedly decrease in the binding affinity for [3H]ketanserin (Kd >10,000 nM). Therefore, it was not possible to find any sarpogrelate affinity to the mutants using [3H]ketanserin. The mutation also abolished agonist-stimulated formation of [3H]inositol phosphates (IP) in both cases. On the other hand, the Trp6.48Ala mutant showed reduced binding affinity for [3H]ketanserin (Kd 2.0 nM vs 0.8 nM for the wild-type receptor) and had reduced affinity for sarpogrelate (pKi value of 5.71 vs 9.06 for the wild-type receptor). The Trp6.48Ala mutant also showed the greatest decrease in sensitivity to sarpogrelate (pKb value 8.81 for wild-type and 5.11 for mutant) in inhibiting agonist-stimulated IP formation. These results provide direct evidence that Asp3.32, Trp3.28, and less importantly, Trp6.48 are responsible for the interaction between the 5-HT2A receptor and sarpogrelate. In addition, these results support the findings obtained from molecular modeling studies.</description><subject>5-HT2A receptor</subject><subject>5-hydroxytryptamine (5-HT)</subject><subject>Amino Acids - metabolism</subject><subject>Animals</subject><subject>Binding, Competitive - drug effects</subject><subject>Blotting, Western</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>Cercopithecus aethiops</subject><subject>COS Cells</subject><subject>DNA - genetics</subject><subject>Humans</subject><subject>Inositol Phosphates - metabolism</subject><subject>Ketanserin - metabolism</subject><subject>Ligands</subject><subject>Models, Molecular</subject><subject>molecular modeling</subject><subject>Mutagenesis, Site-Directed</subject><subject>Receptor, Serotonin, 5-HT2A - genetics</subject><subject>Receptor, Serotonin, 5-HT2A - metabolism</subject><subject>sarpogrelate</subject><subject>Serotonin Antagonists - metabolism</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><subject>site-directed mutagenesis</subject><subject>Succinates - metabolism</subject><subject>Transfection</subject><issn>1347-8613</issn><issn>1347-8648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp1kU2P0zAQhiMEYj_gyhH5D7TYSew4x7KitNJKIBbOlmNPWlepHdku2l747UybbjlxmbHGM898vEXxgdE5K3n9aTdu03z5nVJBWcNeFbesqpuZFLV8fX2z6qa4S2lHaSkpE2-LGybapqaivS3-rC347HpndHbBk9CTxd75QBbGWfIDkrMHSGS9H0PM2mfSh0iedBzDJsKgM5DPzlvnNyQHkrdAVoe99oTPVkcbw_Mxx-OYNRKhXJAniCEH7zyCDYw5xHfFm14PCd5f_H3xa_nl58Nq9vjt6_ph8Tgzggs2kxS44FVntRRl1_Sm5VLW0BjWlLaElnIqG2uEriyXHYVWYqLEuOampQ2v7ov1xLVB79QY3V7HowraqXMgxI3SMTszgDLAGAMhOlu2NfSi1VD3JeubmtlKGo2s-cQyMaQUob_yGFUnUdRJFHUVBQs-TgXjoduD_Zd-UQETllMC_qIQQ_ADHkztwiF6vIoyvUjGgVclIhVltKTs5BSlnKMRVSuxr0DQYgLtUtYbuHZ62e08GJYrdrFYft17q6MCjww5MQD1-O0gqnNvg6NFMBkP5v636F9myMqa</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Muntasir, Habib Abul</creator><creator>Rashid, Mamunur</creator><creator>Komiyama, Tadazumi</creator><creator>Kawakami, Jun</creator><creator>Nagatomo, Takafumi</creator><general>Elsevier B.V</general><general>The Japanese Pharmacological Society</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>2006</creationdate><title>Identification of Amino Acid Residues Important for Sarpogrelate Binding to the Human 5-Hydroxytryptamine2A Serotonin Receptor</title><author>Muntasir, Habib Abul ; Rashid, Mamunur ; Komiyama, Tadazumi ; Kawakami, Jun ; Nagatomo, Takafumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6561-80e5653bda862b7fc95884e7c172d2e905087dc6a3d58b0e98a868e90a5c90753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>5-HT2A receptor</topic><topic>5-hydroxytryptamine (5-HT)</topic><topic>Amino Acids - metabolism</topic><topic>Animals</topic><topic>Binding, Competitive - drug effects</topic><topic>Blotting, Western</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>Cercopithecus aethiops</topic><topic>COS Cells</topic><topic>DNA - genetics</topic><topic>Humans</topic><topic>Inositol Phosphates - metabolism</topic><topic>Ketanserin - metabolism</topic><topic>Ligands</topic><topic>Models, Molecular</topic><topic>molecular modeling</topic><topic>Mutagenesis, Site-Directed</topic><topic>Receptor, Serotonin, 5-HT2A - genetics</topic><topic>Receptor, Serotonin, 5-HT2A - metabolism</topic><topic>sarpogrelate</topic><topic>Serotonin Antagonists - metabolism</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><topic>site-directed mutagenesis</topic><topic>Succinates - metabolism</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muntasir, Habib Abul</creatorcontrib><creatorcontrib>Rashid, Mamunur</creatorcontrib><creatorcontrib>Komiyama, Tadazumi</creatorcontrib><creatorcontrib>Kawakami, Jun</creatorcontrib><creatorcontrib>Nagatomo, Takafumi</creatorcontrib><creatorcontrib>Department of Cardiovascular Medicine</creatorcontrib><creatorcontrib>Department of Pharmacology</creatorcontrib><creatorcontrib>Tohoku University</creatorcontrib><creatorcontrib>Niigata University of Pharmacy and Applied Life Sciences</creatorcontrib><creatorcontrib>Graduate School of Medicine</creatorcontrib><creatorcontrib>Faculty of Pharmaceutical Sciences</creatorcontrib><creatorcontrib>Department of Biochemistry</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Directory of Open Access Journals</collection><jtitle>Journal of Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muntasir, Habib Abul</au><au>Rashid, Mamunur</au><au>Komiyama, Tadazumi</au><au>Kawakami, Jun</au><au>Nagatomo, Takafumi</au><aucorp>Department of Cardiovascular Medicine</aucorp><aucorp>Department of Pharmacology</aucorp><aucorp>Tohoku University</aucorp><aucorp>Niigata University of Pharmacy and Applied Life Sciences</aucorp><aucorp>Graduate School of Medicine</aucorp><aucorp>Faculty of Pharmaceutical Sciences</aucorp><aucorp>Department of Biochemistry</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of Amino Acid Residues Important for Sarpogrelate Binding to the Human 5-Hydroxytryptamine2A Serotonin Receptor</atitle><jtitle>Journal of Pharmacological Sciences</jtitle><addtitle>J Pharmacol Sci</addtitle><date>2006</date><risdate>2006</risdate><volume>102</volume><issue>1</issue><spage>55</spage><epage>63</epage><pages>55-63</pages><issn>1347-8613</issn><eissn>1347-8648</eissn><abstract>The purpose of the present study was to examine 5-hydroxytryptamine (5-HT)2A-receptor sarpogrelate interactions by site-directed mutagenesis. Based on molecular modeling studies, aspartic acid (Asp)155[3.32] and tryptophan (Trp)151[3.28] in transmembrane helix (TMH) III and Trp336[6.48] in TMH VI of the 5-HT2A receptor were found to interact with sarpogrelate. All of these residues were mutated to alanine (Ala). The Asp3.32Ala mutant did not exhibit any affinity for [3H]ketanserin, whereas the Trp3.28Ala mutant showed a markedly decrease in the binding affinity for [3H]ketanserin (Kd >10,000 nM). Therefore, it was not possible to find any sarpogrelate affinity to the mutants using [3H]ketanserin. The mutation also abolished agonist-stimulated formation of [3H]inositol phosphates (IP) in both cases. On the other hand, the Trp6.48Ala mutant showed reduced binding affinity for [3H]ketanserin (Kd 2.0 nM vs 0.8 nM for the wild-type receptor) and had reduced affinity for sarpogrelate (pKi value of 5.71 vs 9.06 for the wild-type receptor). The Trp6.48Ala mutant also showed the greatest decrease in sensitivity to sarpogrelate (pKb value 8.81 for wild-type and 5.11 for mutant) in inhibiting agonist-stimulated IP formation. These results provide direct evidence that Asp3.32, Trp3.28, and less importantly, Trp6.48 are responsible for the interaction between the 5-HT2A receptor and sarpogrelate. In addition, these results support the findings obtained from molecular modeling studies.</abstract><cop>Japan</cop><pub>Elsevier B.V</pub><pmid>16974069</pmid><doi>10.1254/jphs.FP0060171</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1347-8613 |
ispartof | Journal of Pharmacological Sciences, 2006, Vol.102(1), pp.55-63 |
issn | 1347-8613 1347-8648 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_ce111e66bd294ef69ae4f21f741d38ca |
source | ScienceDirect Journals |
subjects | 5-HT2A receptor 5-hydroxytryptamine (5-HT) Amino Acids - metabolism Animals Binding, Competitive - drug effects Blotting, Western Cell Line Cells, Cultured Cercopithecus aethiops COS Cells DNA - genetics Humans Inositol Phosphates - metabolism Ketanserin - metabolism Ligands Models, Molecular molecular modeling Mutagenesis, Site-Directed Receptor, Serotonin, 5-HT2A - genetics Receptor, Serotonin, 5-HT2A - metabolism sarpogrelate Serotonin Antagonists - metabolism Serotonin Receptor Agonists - pharmacology site-directed mutagenesis Succinates - metabolism Transfection |
title | Identification of Amino Acid Residues Important for Sarpogrelate Binding to the Human 5-Hydroxytryptamine2A Serotonin Receptor |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A13%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20Amino%20Acid%20Residues%20Important%20for%20Sarpogrelate%20Binding%20to%20the%20Human%205-Hydroxytryptamine2A%20Serotonin%20Receptor&rft.jtitle=Journal%20of%20Pharmacological%20Sciences&rft.au=Muntasir,%20Habib%20Abul&rft.aucorp=Department%20of%20Cardiovascular%20Medicine&rft.date=2006&rft.volume=102&rft.issue=1&rft.spage=55&rft.epage=63&rft.pages=55-63&rft.issn=1347-8613&rft.eissn=1347-8648&rft_id=info:doi/10.1254/jphs.FP0060171&rft_dat=%3Cpubmed_doaj_%3E16974069%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6561-80e5653bda862b7fc95884e7c172d2e905087dc6a3d58b0e98a868e90a5c90753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/16974069&rfr_iscdi=true |